TransCode Therapeutics Inc (RNAZ)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current RNAZ market cap is 6.13M. The company's latest EPS is USD -20.1363 and P/E is -0.39.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.29M | -5.11M | -2.17M | -5.09M | -3.17M |
| Net Income | -3.33M | -5.19M | -2.32M | -5.95M | -12.09M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -726k | -6.15M | -18.67M | -19.42M | -15.66M |
| Net Income | -2.34M | -6.84M | -17.57M | -18.55M | -16.79M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 7.29M | 4.83M | 3.94M | 7.29M | 13.19M |
| Total Liabilities | 2.71M | 3.5M | 2.28M | 9.31M | 2.9M |
| Total Equity | 4.58M | 1.32M | 1.65M | -2.02M | 10.29M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.06M | 22.94M | 7.59M | 5.17M | 7.29M |
| Total Liabilities | 4.46M | 2.53M | 4.35M | 3.53M | 9.31M |
| Total Equity | -3.41M | 20.4M | 3.24M | 1.64M | -2.02M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.94M | -6.28M | -10.19M | -13.34M | -3.1M |
| Investing | -4k | -8k | -21k | -22k | N/A |
| Financing | 6.09M | 6.87M | 9.32M | 16.4M | 8.86M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -493k | -5.27M | -15.76M | -18.07M | -13.34M |
| Investing | N/A | -252k | -101k | -36k | -22k |
| Financing | 1.12M | 25.52M | 5k | 15.91M | 16.4M |
| Market Cap | 6.13M |
| Price to Earnings Ratio | -0.39 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.12 |
| Price to Book Ratio | -3.22 |
| Dividend Yield | - |
| Shares Outstanding | 833.62k |
| Average Volume (1 week) | 27k |
| Average Volume (1 Month) | 38.14k |
| 52 Week Change | -99.21% |
| 52 Week High | 1,034.88 |
| 52 Week Low | 6.1478 |
| Spread (Intraday) | 1.18 (14.77%) |
| Company Name | TransCode Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.transcodetherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
